1,1-dichloroethene decreases expression ISO RGD:1617605 6480464 vinylidene chloride results in decreased expression of SEMA3E mRNA CTD PMID:26682919 1,2-dimethylhydrazine affects expression ISO RGD:1617605 6480464 1, 2-Dimethylhydrazine affects the expression of SEMA3E mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:1322177 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SEMA3E mRNA CTD PMID:30165855 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1617605 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1322177 6480464 Tetrachlorodibenzodioxin results in increased expression of SEMA3E mRNA CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SEMA3E mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1617605 6480464 Tetrachlorodibenzodioxin results in increased expression of SEMA3E mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1617605 6480464 Tetrachlorodibenzodioxin results in decreased expression of SEMA3E mRNA CTD PMID:19933214 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO RGD:1322177 6480464 2 more ... CTD PMID:26705709 3-Nitrobenzanthrone decreases expression ISO RGD:1322177 6480464 3-nitrobenzanthrone results in decreased expression of SEMA3E mRNA CTD PMID:34036453 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1617605 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of SEMA3E mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO RGD:1617605 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SEMA3E mRNA CTD PMID:30951980 acrylamide increases expression ISO RGD:1617605 6480464 Acrylamide results in increased expression of SEMA3E mRNA CTD PMID:30807115 aflatoxin B1 decreases methylation ISO RGD:1322177 6480464 Aflatoxin B1 results in decreased methylation of SEMA3E gene CTD PMID:27153756 aflatoxin B1 increases methylation ISO RGD:1322177 6480464 Aflatoxin B1 results in increased methylation of SEMA3E intron CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO RGD:1322177 6480464 aflatoxin B2 results in increased methylation of SEMA3E intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1617605 6480464 Tretinoin results in increased expression of SEMA3E mRNA CTD PMID:16604517 all-trans-retinoic acid multiple interactions ISO RGD:1617605 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of SEMA3E mRNA, [bisphenol F co-treated with Tretinoin] results in decreased expression of SEMA3E mRNA CTD PMID:30951980 aristolochic acid A decreases expression ISO RGD:1322177 6480464 aristolochic acid I results in decreased expression of SEMA3E mRNA CTD PMID:33212167 arsenite(3-) increases expression ISO RGD:1617605 6480464 arsenite results in increased expression of SEMA3E mRNA CTD PMID:33053406 belinostat multiple interactions ISO RGD:1322177 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA CTD PMID:27188386 belinostat increases expression ISO RGD:1322177 6480464 belinostat results in increased expression of SEMA3E mRNA CTD PMID:26272509 benzo[a]pyrene decreases expression ISO RGD:1617605 6480464 Benzo(a)pyrene results in decreased expression of SEMA3E mRNA CTD PMID:23735875 benzo[a]pyrene affects methylation ISO RGD:1322177 6480464 Benzo(a)pyrene affects the methylation of SEMA3E exon, Benzo(a)pyrene affects the methylation of SEMA3E intron CTD PMID:27901495 , PMID:30157460 benzo[e]pyrene increases methylation ISO RGD:1322177 6480464 benzo(e)pyrene results in increased methylation of SEMA3E intron CTD PMID:30157460 Benzo[k]fluoranthene decreases expression ISO RGD:1617605 6480464 benzo(k)fluoranthene results in decreased expression of SEMA3E mRNA CTD PMID:26377693 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1617605 6480464 Mustard Gas results in decreased expression of SEMA3E mRNA CTD PMID:15674843 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SEMA3E mRNA CTD PMID:25181051 more ... bisphenol A increases expression ISO RGD:1617605 6480464 bisphenol A results in increased expression of SEMA3E mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SEMA3E gene CTD PMID:28505145 bisphenol F increases expression ISO RGD:1617605 6480464 bisphenol F results in increased expression of SEMA3E mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:1617605 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of SEMA3E mRNA CTD PMID:30951980 carbon nanotube decreases expression ISO RGD:1617605 6480464 Nanotubes more ... CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1322177 6480464 CGP 52608 promotes the reaction [RORA protein binds to SEMA3E gene] CTD PMID:28238834 choline multiple interactions ISO RGD:1617605 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SEMA3E gene CTD PMID:20938992 cisplatin decreases expression ISO RGD:1322177 6480464 Cisplatin results in decreased expression of SEMA3E mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1322177 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of SEMA3E mRNA CTD PMID:27392435 cocaine affects expression EXP 6480464 Cocaine affects the expression of SEMA3E mRNA CTD PMID:15691709 crocidolite asbestos decreases expression ISO RGD:1322177 6480464 Asbestos, Crocidolite results in decreased expression of SEMA3E mRNA CTD PMID:29523930 cyclosporin A decreases expression ISO RGD:1322177 6480464 Cyclosporine results in decreased expression of SEMA3E mRNA CTD PMID:20106945 dorsomorphin multiple interactions ISO RGD:1322177 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1322177 6480464 Doxorubicin results in increased expression of SEMA3E mRNA CTD PMID:30031762 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SEMA3E mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1322177 6480464 entinostat results in increased expression of SEMA3E mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1322177 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO RGD:1617605 6480464 epoxiconazole results in decreased expression of SEMA3E mRNA CTD PMID:35436446 ethanol affects splicing ISO RGD:1617605 6480464 Ethanol affects the splicing of SEMA3E mRNA CTD PMID:30319688 ethanol decreases expression ISO RGD:1617605 6480464 Ethanol results in decreased expression of SEMA3E mRNA CTD PMID:34755883 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of SEMA3E mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:1617605 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SEMA3E gene CTD PMID:20938992 folic acid decreases expression ISO RGD:1617605 6480464 Folic Acid results in decreased expression of SEMA3E mRNA CTD PMID:25629700 folic acid increases expression ISO RGD:1322177 6480464 Folic Acid results in increased expression of SEMA3E mRNA CTD PMID:21867686 genistein increases expression ISO RGD:1617605 6480464 Genistein results in increased expression of SEMA3E mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SEMA3E mRNA CTD PMID:33387578 L-methionine multiple interactions ISO RGD:1617605 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SEMA3E gene CTD PMID:20938992 lead diacetate increases expression ISO RGD:1617605 6480464 lead acetate results in increased expression of SEMA3E mRNA CTD PMID:25270620 lipopolysaccharide multiple interactions ISO RGD:1322177 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SEMA3E mRNA CTD PMID:35811015 mercury dibromide increases expression ISO RGD:1322177 6480464 mercuric bromide results in increased expression of SEMA3E mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1322177 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA CTD PMID:27188386 methapyrilene increases methylation ISO RGD:1322177 6480464 Methapyrilene results in increased methylation of SEMA3E intron CTD PMID:30157460 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of SEMA3E mRNA CTD PMID:34740672 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1322177 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SEMA3E mRNA CTD PMID:24810058 nickel atom decreases expression ISO RGD:1322177 6480464 Nickel results in decreased expression of SEMA3E mRNA CTD PMID:24768652 , PMID:25583101 panobinostat multiple interactions ISO RGD:1322177 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1322177 6480464 panobinostat results in increased expression of SEMA3E mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:1617605 6480464 Acetaminophen affects the expression of SEMA3E mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SEMA3E mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1322177 6480464 Acetaminophen results in decreased expression of SEMA3E mRNA CTD PMID:29067470 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SEMA3E mRNA CTD PMID:32680482 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of SEMA3E mRNA CTD PMID:28511854 phenobarbital affects expression ISO RGD:1322177 6480464 Phenobarbital affects the expression of SEMA3E mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:1322177 6480464 Phenylmercuric Acetate results in increased expression of SEMA3E mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1322177 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1322177 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SEMA3E mRNA CTD PMID:19710929 S-(1,2-dichlorovinyl)-L-cysteine increases expression ISO RGD:1322177 6480464 S-(1, 2-dichlorovinyl)cysteine results in increased expression of SEMA3E mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1322177 6480464 [S-(1, 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of SEMA3E mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1322177 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 senecionine decreases expression ISO RGD:1617605 6480464 senecionine results in decreased expression of SEMA3E protein CTD PMID:35357534 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of SEMA3E mRNA CTD PMID:32721576 sodium arsenite increases expression ISO RGD:1322177 6480464 sodium arsenite results in increased expression of SEMA3E mRNA CTD PMID:17879257 sodium arsenite decreases expression ISO RGD:1617605 6480464 sodium arsenite results in decreased expression of SEMA3E mRNA CTD PMID:36209798 sodium arsenite affects methylation ISO RGD:1322177 6480464 sodium arsenite affects the methylation of SEMA3E gene CTD PMID:28589171 succimer multiple interactions ISO RGD:1617605 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA3E mRNA CTD PMID:21641980 sunitinib decreases expression ISO RGD:1322177 6480464 Sunitinib results in decreased expression of SEMA3E mRNA CTD PMID:31533062 temozolomide decreases expression ISO RGD:1322177 6480464 Temozolomide results in decreased expression of SEMA3E mRNA CTD PMID:31758290 tetrachloromethane increases expression ISO RGD:1617605 6480464 Carbon Tetrachloride results in increased expression of SEMA3E mRNA CTD PMID:31919559 titanium dioxide decreases expression ISO RGD:1617605 6480464 titanium dioxide results in decreased expression of SEMA3E mRNA CTD PMID:23557971 , PMID:27760801 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of SEMA3E gene CTD PMID:27618143 trichostatin A increases expression ISO RGD:1322177 6480464 trichostatin A results in increased expression of SEMA3E mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1322177 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1322177 6480464 Triclosan results in decreased expression of SEMA3E mRNA CTD PMID:30510588 trovafloxacin decreases expression ISO RGD:1617605 6480464 trovafloxacin results in decreased expression of SEMA3E mRNA CTD PMID:35537566 valproic acid affects expression ISO RGD:1322177 6480464 Valproic Acid affects the expression of SEMA3E mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1322177 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1322177 6480464 Valproic Acid results in increased expression of SEMA3E mRNA CTD PMID:23179753 more ... vorinostat multiple interactions ISO RGD:1322177 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA CTD PMID:27188386 vorinostat increases expression ISO RGD:1322177 6480464 vorinostat results in increased expression of SEMA3E mRNA CTD PMID:26272509 zinc atom increases expression ISO RGD:1322177 6480464 Zinc deficiency results in increased expression of SEMA3E mRNA CTD PMID:22171008 zinc(0) increases expression ISO RGD:1322177 6480464 Zinc deficiency results in increased expression of SEMA3E mRNA CTD PMID:22171008
